Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on December 4, 2008

Arteriosclerosis, Thrombosis, and Vascular Biology. 2008
Published online before print December 4, 2008, doi: 10.1161/ATVBAHA.108.165506
A more recent version of this article appeared on July 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
29/7/992    most recent
ATVBAHA.108.165506v2
ATVBAHA.108.165506v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cormode, D. P.
Right arrow Articles by Mulder, W. J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cormode, D. P.
Right arrow Articles by Mulder, W. J. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Diagnostic Imaging

Submitted on October 9, 2008
Accepted on November 24, 2008

Nanotechnology in Medical Imaging. Probe Design and Applications

David P. Cormode ; Torjus Skajaa ; Zahi A. Fayad ; and Willem J. M. Mulder *

From the Translational and Molecular Imaging Institute (D.P.C., T.S., Z.A.F., W.J.M.M.), Mount Sinai School of Medicine, New York; and the Faculty of Health Sciences (T.S.), Århus University, Denmark.

* To whom correspondence should be addressed. E-mail: Willem.Mulder{at}Mountsinai.org.

Abstract—Nanoparticles have become more and more prevalent in reports of novel contrast agents, especially for molecular imaging, the detection of cellular processes. The advantages of nanoparticles include their potency to generate contrast, the ease of integrating multiple properties, lengthy circulation times, and the possibility to include high payloads. As the chemistry of nanoparticles has improved over the past years, more sophisticated examples of nano-sized contrast agents have been reported, such as paramagnetic, macrophage targeted quantum dots or {alpha}v{beta}3-targeted, MRI visible microemulsions that also carry a drug to suppress angiogenesis. The use of these particles is producing greater knowledge of disease processes and the effects of therapy. Along with their excellent properties, nanoparticles may produce significant toxicity, which must be minimized for (clinical) application. In this review we discuss the different factors that are considered when designing a nanoparticle probe and highlight some of the most advanced examples.


Key words: nanotechnology • molecular imaging • magnetic resonance imaging • drug delivery • gene therapy




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Z. A. Fayad
Cardiovascular Molecular Imaging
Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 981 - 982.
[Full Text] [PDF]